BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Diabetes mellitus, Breast, Anticancer prodrugs, Acetaminophen, rs3825942)
Bookmark Forward

QuickView for glypican 3 (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal liver
  2. Placenta
  3. Fetal lung
  4. Omental adipose tissue
  5. Dorsal root ganglia
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Liver cancer
  2. Inflammatory disease of liver
  3. Duchenne muscular dystrophy
  4. Kidney cancer
  5. Gastrointestinal hemorrhage
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. combretastatin A-4
  2. PD 184352
  3. AS 601245
  4. Apitolisib
  5. Bmp4 protein, mouse
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PLAC8
  2. TLR4
  3. GRB14
  4. FHL2
  5. LEP
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 M…
  2. A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma.
  3. A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular…
  4. Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mic…
  5. Gasdermin D-mediated pyroptosis suppresses liver regeneration after 70% partial hepatectomy.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients
  2. 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
  3. Chimeric Antigen Receptor T Cells Targeting Glypican-3
  4. Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid…
  5. Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCA…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.